PDE-5 Inhibitors (Sildenafil / Tadalafil) vs PT-141 (Bremelanotide / Vyleesi)
Both are used for sexual health. Here's how they compare on human evidence, mechanism, safety and availability — in plain English.
| PDE-5 Inhibitors (Sildenafil / Tadalafil) | PT-141 (Bremelanotide / Vyleesi) | |
|---|---|---|
| Human evidence | ★★★★★ | ★★★★☆ |
| Legal status | FDA Approved | FDA Approved, Not Approved |
| How it works | Inhibit phosphodiesterase-5 (PDE5A), preserving cGMP → sustained nitric-oxide-driven vasodilation in erectile tissue; tadalafil's long half-life also aids BPH and is studied for endothelial/longevity effects. | α-MSH-derived peptide activating central melanocortin receptors MC3R/MC4R in brain desire/reward circuits — acting on libido centrally, unlike PDE-5 drugs (which act on blood flow). |
| In plain English | Keeps blood vessels relaxed and blood flowing where it's needed. Extremely well-established; daily low-dose tadalafil also has vascular-health interest. | Works in the brain's desire centre rather than on plumbing — FDA-approved for low sexual desire in premenopausal women, used off-label by men. |
| Bottom line | Gold-standard ED treatment; low-dose daily has broader vascular appeal. | The only centrally-acting approved libido drug. |
| Availability | Available over the counter | Not widely approved |
Which is better for sexual health?
PDE-5 Inhibitors (Sildenafil / Tadalafil) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
Full breakdowns: PDE-5 Inhibitors (Sildenafil / Tadalafil) · PT-141 (Bremelanotide / Vyleesi).
Common questions
Is PDE-5 Inhibitors (Sildenafil / Tadalafil) or PT-141 (Bremelanotide / Vyleesi) better for sexual health?
PDE-5 Inhibitors (Sildenafil / Tadalafil) has the stronger human-evidence rating (★★★★★ vs ★★★★☆), but the right choice still depends on your goal, tolerance and budget.
What's the difference between PDE-5 Inhibitors (Sildenafil / Tadalafil) and PT-141 (Bremelanotide / Vyleesi)?
PDE-5 Inhibitors (Sildenafil / Tadalafil): Gold-standard ED treatment; low-dose daily has broader vascular appeal. — PT-141 (Bremelanotide / Vyleesi): The only centrally-acting approved libido drug.